Sign InBreakout Stocks of Week 17 @ NSE
NASDAQ was up by impressive 6.84% last week (week 16) ending at 24,468.48 points points after ending the week prior at 22,902.89 points. Normally this would indicate a weaker week ahead of us. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Ipca Laboratories Limited NSE:IPCALAB. This stock has had a buy signal since Feb 11, 2026 when the price was ₹1,432.70 and is so far up 2.48% to ₹1,468.30. Some other companies are on our watchlist to, among these are United Breweries Limited NSE:UBL Ajanta Pharma Limited NSE:AJANTPHARM Sun Pharmaceutical Industries Limited NSE:SUNPHARMA and G.M.Breweries Limited NSE:GMBREW which all got a breakout pattern emerging.
| Date | Company | Price | Week 17 |
|---|---|---|---|
| Ipca Laboratories Limited | ₹1,468.30 | ₹1,555.90 | 5.97% |
| United Breweries Limited | ₹1,493.60 | ₹1,477.10 | -1.10% |
| Ajanta Pharma Limited | ₹2,790.20 | ₹2,765.30 | -0.89% |
| Sun Pharmaceutical Industries Limited | ₹1,675.50 | ₹1,620.40 | -3.29% |
| G.m.breweries Limited | ₹986.95 | ₹961.00 | -2.63% |
The Ipca Laboratories Limited stock price gained 0.472% on the last trading day (Friday, 17th Apr 2026), rising from ₹1,461.40 to ₹1,468.30. During the last trading day the stock fluctuated 1.29% from a day low at ₹1,456.20 to a day high of ₹1,475.00. The price has been going up and down for this period, and there has been a -2.65% loss for the last 2 weeks. Volume fell on the last day by -73 thousand shares and in total, 115 thousand shares were bought and sold for approximately ₹168.22 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ipca Laboratories Limited stock to perform well in the short-term.
The United Breweries Limited stock price gained 2.36% on the last trading day (Friday, 17th Apr 2026), rising from ₹1,459.20 to ₹1,493.60. During the last trading day the stock fluctuated 4.10% from a day low at ₹1,455.40 to a day high of ₹1,515.00. The price has fallen in 6 of the last 10 days and is down by -5.72% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 344 thousand shares were bought and sold for approximately ₹514.19 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for United Breweries Limited stock to perform well in the short-term.
About United Breweries Limited:
United Breweries Limited manufactures, purchases, and sells beer and non-alcoholic beverages in India and internationally. It offers its products under the Kingfisher Premium, Kingfisher Strong, Kingfisher Ultra, Kingfisher Ultra Max, Kingfisher Ultra Witbier, Kingfisher Storm, and Kingfisher Blue, as well as Heineken, Amstel Bier, Sol, Affligem, Edelweiss, Desperados, Bullet, Cannon 10000, Zingaro, Kalyani Black Label, UB Export, UB Export Strong, London Pilsner, and London Pilsner Strong brand names. The company also exports its products; licenses its brands; and offers contract manufacturing services. United Breweries Limited was founded in 1915 and is based in Bengaluru, India. As of June 23, 2021, United Breweries Limited operates as a subsidiary of Heineken International B.V.
The Ajanta Pharma Limited stock price fell by -1.32% on the last day (Friday, 17th Apr 2026) from ₹2,827.60 to ₹2,790.20. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.99% from a day low at ₹2,782.60 to a day high of ₹2,865.90. The price has fallen in 7 of the last 10 days and is down by -0.94% for this period. Volume has increased on the last day by 27 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 115 thousand shares were bought and sold for approximately ₹319.51 million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Ajanta Pharma Limited:
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.
The Sun Pharmaceutical Industries Limited stock price fell by -1.04% on the last day (Friday, 17th Apr 2026) from ₹1,693.10 to ₹1,675.50. During the last trading day the stock fluctuated 1.58% from a day low at ₹1,670.50 to a day high of ₹1,696.90. The price has fallen in 6 of the last 10 days and is down by -3.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 3 million shares were bought and sold for approximately ₹5.27 billion.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Sun Pharmaceutical Industries Limited:
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.
The G.M.Breweries Limited stock price gained 1.31% on the last trading day (Friday, 17th Apr 2026), rising from ₹974.20 to ₹986.95. During the last trading day the stock fluctuated 2.62% from a day low at ₹971.00 to a day high of ₹996.40. The price has been going up and down for this period, and there has been a -5.91% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 51 thousand more shares were traded than the day before. In total, 147 thousand shares were bought and sold for approximately ₹145.12 million.
G.M.Breweries Limited holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About G.M.Breweries Limited:
G.M. Breweries Limited manufactures and sells alcoholic liquor in India. The company's alcoholic beverages include Indian made foreign liquor and country liquor. It offers its products under the G.M.SANTRA, G.M.DOCTOR, G.M.LIMBU PUNCH, and G.M.DILBAHAR SOUNF brand names. The company was incorporated in 1981 and is based in Mumbai, India.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
LITE
$905.00
|
3.65% | Jun 01 |
RUN
$12.83
|
15.74% | May 06 |
GLBE
$31.61
|
0.569% | May 05 |
SAP
$172.39
|
4.80% | May 05 |
ADBE
$243.57
|
5.20% | Apr 29 |
